Depression

Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.

Experts discuss how practitioners are viewing major depressive disorder (MDD) as a chronic condition vs an episodic condition.

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss navigating the challenge of a “one size fits all approach” when treating and identifying the specific needs of patients with major depressive disorder (MDD).

Here’s everything you need to know to about how to integrate apps into your clinical practice.

From research updates on at-home ketamine use to the effects of comorbid depression and anxiety on insomnia treatment, here are highlights from the week in Psychiatric Times.

Fatigue: a very common physical complaint that often accompanies depressive disorders.

New research finds depressive and anxiety symptoms impact effectiveness of cognitive behavioral therapy for insomnia.

1 in 5 respondents reported using psychedelic drugs for the purpose of self-treating anxiety, depression, or other mental illnesses.

From obesity and metabolism in first-episode MDD to psychiatrist liability and suicide, here are highlights from the week in Psychiatric Times.

PME affects many women, yet it remains under-recognized in clinical practice and in research.

Metabolic mediators of anxious depression? Researchers investigated metabolic correlates of overweight/obesity in patients with MDD.

Looking to stay up to date on MDD research? This research collection reviews outcomes on metabolic abnormalities, biomarkers, and more.

Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression.

Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.

An inside look at what treatments are being discussed in San Francisco...

Does treatment-resistant depression exist? These 2023 APA Annual Meeting panelists discuss definitions in this exclusive video.

Study results presented at the 2023 American Psychiatric Association Annual Meeting.

A look at the theme for the 2023 American Psychiatric Association Annual Meeting.

Don't miss this session at the APA 2023 Annual Meeting in San Francisco!

Study investigates connections between rTMS and factors including depression and cognitive performance.

Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?

When considering transcranial magnetic stimulation as a treatment option for treatment-resistant depression, here are some key questions to ask the patient.

Test your knowledge on issues in major depressive disorder.

When the Surgeon General notices the loneliness problem, it is definitely a mayday moment.

“Our hope for patients suffering from TRD is that their serious, but often treatable condition is recognized earlier in the treatment paradigm, and they are put on a treatment that works best for their specific type of depression.”